|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001737,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0087111,
umls-concept:C0220825,
umls-concept:C0443281,
umls-concept:C0449445,
umls-concept:C1521797,
umls-concept:C1705493,
umls-concept:C1708528,
umls-concept:C2936491
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2007-8-31
|
|
pubmed:abstractText |
Highly active antiretroviral treatment (HAART) has only been recently recommended for HIV-infected pregnant women requiring treatment for their own health in resource-limited settings. However, there are few documented experiences from African countries. We evaluated the short-term (4 wk) and long-term (12 mo) effectiveness of a two-tiered strategy of prevention of mother-to-child transmission of HIV (PMTCT) in Africa: women meeting the eligibility criteria of the World Health Organization (WHO) received HAART, and women with less advanced HIV disease received short-course antiretroviral (scARV) PMTCT regimens.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-10432324,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-10459958,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-10459959,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-10485720,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-11873008,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-11955535,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-11981365,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-12063370,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-12599045,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-15181561,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-15213559,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-15247338,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-15365003,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-15577551,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-15668871,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-15718842,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-15942891,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-15956387,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-16035607,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-16088820,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-16425126,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-16586354,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-16945080,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-17117021,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17713983-9416366
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1549-1676
|
|
pubmed:author |
pubmed-author:AbramsElaine JEJ,
pubmed-author:Amani-BosseClarisseC,
pubmed-author:BecquetRenaudR,
pubmed-author:CoffiePatrick APA,
pubmed-author:DabisFrançoisF,
pubmed-author:El-SadrWafaa MWM,
pubmed-author:HurstC ECE,
pubmed-author:LeroyValérianeV,
pubmed-author:RouetFrançoisF,
pubmed-author:Tonwe-GoldBesiginB,
pubmed-author:ToureSiakaS,
pubmed-author:VihoIdaI
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e257
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17713983-Anti-HIV Agents,
pubmed-meshheading:17713983-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:17713983-Breast Feeding,
pubmed-meshheading:17713983-CD4 Lymphocyte Count,
pubmed-meshheading:17713983-Cohort Studies,
pubmed-meshheading:17713983-Cote d'Ivoire,
pubmed-meshheading:17713983-Female,
pubmed-meshheading:17713983-Follow-Up Studies,
pubmed-meshheading:17713983-HIV Infections,
pubmed-meshheading:17713983-HIV-1,
pubmed-meshheading:17713983-Humans,
pubmed-meshheading:17713983-Infant,
pubmed-meshheading:17713983-Infant, Low Birth Weight,
pubmed-meshheading:17713983-Infant, Newborn,
pubmed-meshheading:17713983-Infectious Disease Transmission, Vertical,
pubmed-meshheading:17713983-Lamivudine,
pubmed-meshheading:17713983-Male,
pubmed-meshheading:17713983-Nevirapine,
pubmed-meshheading:17713983-Pregnancy,
pubmed-meshheading:17713983-Pregnancy Complications, Infectious,
pubmed-meshheading:17713983-Program Evaluation,
pubmed-meshheading:17713983-Puerperal Disorders,
pubmed-meshheading:17713983-Viral Load,
pubmed-meshheading:17713983-Zidovudine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
|
|
pubmed:affiliation |
MTCT-Plus Programme, ACONDA, Abidjan, Côte d'Ivoire.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
